Page updated Jan. 31, 2023

Pacific continues to require all students and employees to be fully vaccinated against COVID-19 and to get their booster dose as soon as they are eligible.

In addition to the COVID-19 vaccine, Pacific requires students to obtain other immunizations. See the Immunization Requirement page for more information.

Pacific frequently hosts vaccination clinics for the community. Dates and sign-up information is available through California's MyTurn. Upcoming COVID-19 vaccination clinics:

Stockton (use ZIP code 95211)

  • February 3, 2023, 11-1 p.m. – Flu, COVID and M-Pox Vaccine Clinic
    • Where: DeRosa University Center (DUC)
    • How: Walk In 

Questions? Call Student Health Services at 209-946-2315 Opt. 1


  • TBA

San Francisco

  • TBA

Pfizer Dose 1, 2, Additional and booster are typically available at Stockton, Sacramento and San Francisco campuses; Moderna boosters are available at San Francisco clinics if supply allows.

In accordance with Cal/OSHA Standards, employees must inform Pacific of their vaccination status to facilitate development of workplace protocols.


Upload Vaccination Status

If you have received your COVID-19 vaccine and/or booster somewhere other than Pacific, please follow these instructions to upload proof.

If you have been fully vaccinated at one of Pacific’s COVID-19 vaccine clinics, we already have recorded this information in the university’s secure medical records system. You do not need to do anything at this time.

Student vaccination records are confidential and protected under FERPA.

Employee vaccination records are confidential and protected under the CMIA.


COVID-19 Vaccine Exemption

If an individual chooses not to be vaccinated (or boosted, if eligible), for health or religion reasons, they must complete and submit a declination form (pdf).

To upload declination form:


Vaccinated Outside of the United States

Individuals who were vaccinated outside the United States with a COVID-19 vaccine approval by the World Health Organization, an FDA-authorized COVID-19 vaccine and have received all the recommended doses do not need any additional doses, but may be eligible for an Additional or Booster dose based on current public health recommendations. People who received the first dose of an authorized COVID-19 vaccine that requires two doses do not need to restart the vaccine series in the United States but should receive the second dose as close to the recommended time as possible.

Some people may have received a COVID-19 vaccine that is not currently authorized in the United States. No data are available on the safety or efficacy of receiving a COVID-19 vaccine currently authorized in the United States after receipt of a non-FDA-authorized COVID-19 vaccine. However, in some circumstances people who received a COVID-19 vaccine not currently authorized in the United States may be offered revaccination with an FDA-authorized vaccine:

WHO has listed the following COVID-19 vaccines for emergency use*:

  • Pfizer-BioNTech COVID-19 Vaccines (e.g., BNT162b2, COMIRNATY, Tozinameran)
  • AstraZeneca-Oxford COVID-19 Vaccines (e.g., [ChAdOx1-S (recombinant)], AZD1222, Covishield, Vaxzevria)
  • Janssen (Johnson & Johnson) COVID-19 Vaccine (e.g., Ad26.COV2.S)
  • Moderna COVID-19 Vaccine (e.g., mRNA 1273, Takeda, Spikevax)
  • Sinopharm-BIBP COVID-19 Vaccine
  • Sinovac-CoronaVac COVID-19 Vaccine
  • Bharat Biotech International COVID-19 Vaccines (e.g., BBV152, COVAXIN)

*As of Nov. 22, 2021. Due to frequent updates, newly approved vaccines may not be listed.

The minimum interval between the last dose of a non-FDA authorized vaccine or a WHO-listed vaccine and an FDA-authorized COVID-19 vaccine is 28 days. Only people who have received all recommended doses of an FDA-authorized or WHO-listed COVID-19 vaccine are considered fully vaccinated for the purpose of public health guidance.